Frontlight ResearchEarly access
Liver and biliary tract cancer trials in Bangladesh
1 trial · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleComparison of Response Between Combination of Transarterial Chemoembolization and Lenvatinib Therapy Versus Lenvatinib Monotherapy in Patients With Unresectable Hepatocellular Carcinoma
- Where
- Dhaka
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Bangladesh Medical University
See details and how to joinNCT07408804